Abstract
Aim: This study presents an improved method based on “Gorji et al. Neuroscience. 2015” by introducing a relatively new classifier—linear regression classification.
Method: Our method selects one axial slice from 3D brain image, and employed pseudo Zernike moment with maximum order of 15 to extract 256 features from each image. Finally, linear regression classification was harnessed as the classifier. Results: The proposed approach obtains an accuracy of 97.51%, a sensitivity of 96.71%, and a specificity of 97.73%. Conclusion: Our method performs better than Gorji’s approach and five other state-of-the-art approaches.Keywords: Alzheimer’s disease, linear regression classification, pseudo Zernike moment.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Alzheimer’s Disease Detection by Pseudo Zernike Moment and Linear Regression Classification
Volume: 16 Issue: 1
Author(s): Shui-Hua Wang, Sidan Du, Yin Zhang, Preetha Phillips, Le-Nan Wu, Xian-Qing Chen and Yu-Dong Zhang
Affiliation:
Keywords: Alzheimer’s disease, linear regression classification, pseudo Zernike moment.
Abstract: Aim: This study presents an improved method based on “Gorji et al. Neuroscience. 2015” by introducing a relatively new classifier—linear regression classification.
Method: Our method selects one axial slice from 3D brain image, and employed pseudo Zernike moment with maximum order of 15 to extract 256 features from each image. Finally, linear regression classification was harnessed as the classifier. Results: The proposed approach obtains an accuracy of 97.51%, a sensitivity of 96.71%, and a specificity of 97.73%. Conclusion: Our method performs better than Gorji’s approach and five other state-of-the-art approaches.Export Options
About this article
Cite this article as:
Wang Shui-Hua, Du Sidan, Zhang Yin, Phillips Preetha, Wu Le-Nan, Chen Xian-Qing and Zhang Yu-Dong, Alzheimer’s Disease Detection by Pseudo Zernike Moment and Linear Regression Classification, CNS & Neurological Disorders - Drug Targets 2017; 16 (1) . https://dx.doi.org/10.2174/1871527315666161111123024
DOI https://dx.doi.org/10.2174/1871527315666161111123024 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimers Disease
Current Genomics Editorial [Hot topic: Adenosine Receptor Ligands: Where Are We, and Where Are We Going? (Guest Editors: Tiziano Tuccinardi and Adriano Martinelli)]
Current Topics in Medicinal Chemistry Natural Products and their (Semi-)Synthetic Forms in the Treatment of Migraine: History and Current Status
Current Medicinal Chemistry Neuroprotective Effects of Ellagic Acid in Alzheimer's Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential
Current Pharmaceutical Design Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) Conformations and Biological Activities of Amyloid Beta Peptide 25-35
Current Protein & Peptide Science The Interrelationship Between Disease and Ageing and the Implications for Longevity
Current Aging Science Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Metabolic Syndrome and Non-Cardiac Vascular Diseases: An Update from Human Studies
Current Pharmaceutical Design Targeting Stress Activated Protein Kinases, JNK and p38, as New Therapeutic Approach for Neurodegenerative Diseases
Central Nervous System Agents in Medicinal Chemistry Targeting Neuronal Nicotinic Receptors: a Path to New Therapies
Current Drug Targets - CNS & Neurological Disorders Nutraceuticals and "Repurposed" Drugs of Phytochemical Origin in Prevention and Interception of Chronic Degenerative Diseases and Cancer
Current Medicinal Chemistry Subcutaneous Immunoglobulins: A Promising Alternative for Immunomodulation?
Current Pharmaceutical Design Pleiotropic Effects of the Rho-kinase Inhibitor Fasudil After Subarachnoid Hemorrhage: A Review of Preclinical and Clinical Studies
Current Vascular Pharmacology Thin, Stubby or Mushroom: Spine Pathology in Alzheimers Disease
Current Alzheimer Research Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases
Current Drug Targets Vascular Disease and Insulin-Like Growth Factor-1
Vascular Disease Prevention (Discontinued) Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeo - static Signaling
Current Psychopharmacology Advances in Stem Cells Transplantation for the Therapy of Parkinson’s Disease
Current Stem Cell Research & Therapy